ENROLLING_BY_INVITATION

IMProving Adherence to Colonoscopy Through Teams and Technology

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Complete and timely colonoscopy after an abnormal stool-based colorectal cancer screening test results in early detection, cancer prevention, and reduction in mortality, but follow-up in safety-net health systems occurs in less than 50% at 6 months. The proposal will implement multi-level approach consisting of a stepped-wedge clinic-level intervention of team-based best practices co-developed with primary and specialty care, a patient-level technology intervention to provide enhanced instructions and navigation to complete diagnostic colonoscopy, and a mixed methods evaluation to explore multi-level factors contributing to intervention outcomes. Developing a solution to this high-risk and diverse population has the potential to translate to other health systems, support patient self-management, and address other patient conditions.

Official Title

IMProving Adherence to Colonoscopy Through Teams and Technology

Quick Facts

Study Start:2024-07-08
Study Completion:2027-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ENROLLING_BY_INVITATION

Study ID

NCT06191185

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients with abnormal FIT result
  2. * Patients ages 18 years or older
  3. * English, Spanish, or Cantonese speaking
  1. * Patients with normal FIT result
  2. * Patients younger than age 18

Contacts and Locations

Principal Investigator

Urmimala Sarkar, MD, MPH
PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Ma Somsouk, MD, MAS
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

Zuckerberg San Francisco General Hospital
San Francisco, California, 94110
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Urmimala Sarkar, MD, MPH, PRINCIPAL_INVESTIGATOR, University of California, San Francisco
  • Ma Somsouk, MD, MAS, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-08
Study Completion Date2027-03

Study Record Updates

Study Start Date2024-07-08
Study Completion Date2027-03

Terms related to this study

Additional Relevant MeSH Terms

  • Colon Cancer
  • Cancer Colorectal
  • Colorectal Cancer